Biotech

All Articles

Former Seagen chief executive officer unveils brand-new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was offered to Pfizer in 2014 for a tremendous $4...

Ironwood makes more bid for $1B GI medicine with new subgroup information

.On the heels of a stage 3 win that stopped working to impress investors, Ironwood Pharmaceuticals i...

Novartis inks $150M package for autoimmune molecular glue

.Don't stop Monte Rosa Therapies right now. The Boston-based biotech is actually enjoying after sign...

Jade takes exec staff along with Chinook veterinarians-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings ...

Septerna goes public along with upsized offering of $288M

.Celebrating his company's upsized going public (IPO), Septerna chief executive officer Jeffrey Fine...

AbbVie creates Richter richer, paying out $25M to form finding deal

.AbbVie has returned to the source of its antipsychotic powerhouse Vraylar searching for another run...

GenSight enters into ultimate weeks of money path as earnings stream noses out of grasp

.GenSight Biologics is actually full weeks far from lacking funds. Again. The biotech simply possess...

AZ licenses thrown away rare disease drug to Monopar Therapeutics

.Monopar Rehabs is recuperating a drug from the dump of AstraZeneca's unusual health condition pipe....

Arcus' brand new HIF-2a data in renal cancer mention prospective upper hand over Merck's Welireg, experts point out

.With brand new data out on Arcus Biosciences' speculative HIF-2a prevention, one team of analysts e...

Roche wagers up to $1B to extend Dyno gene therapy shipping contract

.After forming a gene treatment relationship along with Dyno Rehabs in 2020, Roche is back for addit...